Hennion & Walsh Asset Management, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.06 Billion
- Q3 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 54,274 shares of HRMY stock, worth $1.8 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
54,274
Previous 44,945
20.76%
Holding current value
$1.8 Million
Previous $1.36 Million
60.0%
% of portfolio
0.11%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding HRMY
# of Institutions
227Shares Held
45.1MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$371 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$116 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$86.2 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$83 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.96B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...